Cited by 508Immune cells in cancerSarcoma Diagnosis and TreatmentCancer Cells and Metastasis

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Buddingh, Emilie P., Kuijjer, Marieke L., Duim, Ronald A.J., Bürger, Horst, Agelopoulos, Konstantin, Myklebost, Ola, Serra, Massimo, Mertens, Fredrik, Hogendoorn, Pancras C.W., Lankester, Arjan C., Cleton-Jansen, Anne-Marie·2011·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-10-2047

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Purpose: High-grade osteosarcoma is a malignant primary bone tumor with a peak incidence in adolescence. Overall survival (OS) of patients with resectable metastatic disease is approximately 20%. The exact mechanisms of development of metastases in osteosarcoma remain unclear. Most studies focus on tumor cells, but it is increasingly evident that stroma plays an important role in tumorigenesis and metastasis. We investigated the development of metastasis by studying tumor cells and their stromal context. Experimental Design: To identify gene signatures playing a role in metastasis, we carried out genome-wide gene expression profiling on prechemotherapy biopsies of patients who did (n = 34) and patients who did not (n = 19) develop metastases within 5 years. Immunohistochemistry (IHC) was performed on pretreatment biopsies from 2 additional cohorts (n = 63 and n = 16) and corresponding postchemotherapy resections and metastases. Results: A total of 118/132 differentially expressed genes were upregulated in patients without metastases. Remarkably, almost half of these upregulated genes had immunological functions, particularly related to macrophages. Macrophage-associated genes were expressed by infiltrating cells and not by osteosarcoma cells. Tumor-associated macrophages (TAM) were quantified with IHC and associated with significantly better overall survival (OS) in the additional patient cohorts. Osteosarcoma samples contained both M1- (CD14/HLA-DRα positive) and M2-type TAMs (CD14/CD163 positive and association with angiogenesis). Conclusions: In contrast to most other tumor types, TAMs are associated with reduced metastasis and improved survival in high-grade osteosarcoma. This study provides a biological rationale for the adjuvant treatment of high-grade osteosarcoma patients with macrophage activating agents, such as muramyl tripeptide. Clin Cancer Res; 17(8); 2110–9. ©2011 AACR.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-2047

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,349
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
Bielack, S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.776 · Cited by 2,391
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
lumi : a pipeline for processing Illumina microarray
Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,028
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712

Show all 45 references

Research works printed but not linked: 2

Raymond, 2002, Conventional osteosarcoma, 264
2005, R: a language and environment for statistical computing, reference index version 2.9.0.

Sorted by citations

Items 301–400 of 504

Gene signatures with predictive and prognostic survival values in human osteosarcoma
Qiu, Z., Du, X., Chen, K., Dai, Y., Wang, S., Xiao, J., & Li, G. (2021) · PeerJ · doi:10.7717/peerj.10633 · Cited by 11
Drug Delivery Platform Targeting MMP9 in Combination with Photothermal Therapy to Improve Tumor Chemosensitivity
Fu, J., Song, C., Jiang, S., Yang, S., Wu, Q., Liu, X., Hong, Z., Rouhan, A., Li, B., Qu, G., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500174 · Cited by 10
Infiltration of LPAR5+ macrophages in osteosarcoma tumor microenvironment predicts better outcomes
He, Y., Zhou, H., Huang, X., Qu, Y., Wang, Y.-G., Pei, W., Zhang, R., Chen, S., & You, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909932 · Cited by 10
Identification of an EMT‐related gene‐based prognostic signature in osteosarcoma
Gong, H., Ye, T., Xiao, S., Li, X., Fang, K., Wen, J., Zeng, M., Liu, Y., & Yang, C. (2023) · Cancer Medicine · doi:10.1002/cam4.5942 · Cited by 10
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
Buddingh, E. P., Ruslan, S. E. N., Reijnders, C. M. A., Szuhai, K., Kuijjer, M. L., Roelofs, H., Hogendoorn, P. C. W., Egeler, R. M., Cleton-Jansen, A., & Lankester, A. C. (2015) · Clinical Sarcoma Research · doi:10.1186/s13569-015-0031-1 · Cited by 10
Self-citation
Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis
Liu, D., Zhou, R., & Zhou, A. (2021) · Medicine · doi:10.1097/md.0000000000024471 · Cited by 10
CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
Han, R., Li, J., Hony, J., Xiao, Z., wang, J., Yao, M., Liang, S., & Lu, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1052657 · Cited by 10
Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
Wu, F., Xu, J., Jin, M., Jiang, X., Li, J., Li, X., Chen, Z., Nie, J., Meng, Z., & Wang, G. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.705148 · Cited by 10
GD2-mediated impairment of macrophage phagocytosis drives pulmonary metastasis in osteosarcoma
He, Y., Yang, P. H., Ding, P., Zhang, Z., Wu, J., Wang, C., Hou, G., Ge, J., Zhou, Q., Song, Z., et al. (2025) · Theranostics · doi:10.7150/thno.113887 · Cited by 9
Decoding osteosarcoma from heterogeneity to precision therapy
Xu, Y., Bai, Y., Yang, F., Yang, B., Huang, Z., Su, L., & Peng, K. (2025) · Discover Oncology · doi:10.1007/s12672-025-04256-7 · Cited by 9
Chemokines and Bone
Gilchrist, A., & Stern, P. H. (2015) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-015-9184-y · Cited by 9
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
Zalacaín, M., Buñuales, M., Marrodán, L., Labiano, S., González-Huarriz, M., Martínez-Vélez, N., Laspidea, V., Puigdelloses, M., García-Moure, M., González-Aparicio, M., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.11.003 · Cited by 9
Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma
Yu, L., Sun, H., & Chen, Y. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01617-5 · Cited by 9
A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma
Chen, P., & Shen, J. (2023) · Bioengineering · doi:10.3390/bioengineering10101121 · Cited by 9
Osteoimmunology in bone malignancies: a symphony with evil
Song, C., Tong, T., Dai, B., Zhu, Y., Chen, E., Zhang, M., & Zhang, W. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.09.001 · Cited by 10
Prediction of optimal gene functions for osteosarcoma using gene ontology and microarray profiles
Chen, X.-R. (2017) · Journal of bone oncology · doi:10.1016/j.jbo.2017.04.003 · Cited by 9
Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
Liu, S., Liu, J., Yu, X. B., Shen, T., & Fu, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01578 · Cited by 9
Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
van Oost, S., Meijer, D. M., Kuijjer, M. L., Bovée, J. V. M. G., & de Miranda, N. F. C. C. (2021) · Biomedicines · doi:10.3390/biomedicines9081048 · Cited by 9
Self-citation
Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma
Zheng, S., Liu, Y., Sun, H., Jia, J., Wu, T., Ding, R., & Cheng, X. (2021) · European Journal of Histochemistry · doi:10.4081/ejh.2021.3264 · Cited by 9
The perplexing role of immuno-oncology drugs in osteosarcoma
Smrke, A., Tam, Y. B., Anderson, P. M., Jones, R. L., & Huang, P. H. (2021) · Journal of bone oncology · doi:10.1016/j.jbo.2021.100400 · Cited by 9
The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies
Holterhus, M., Altvater, B., Kailayangiri, S., & Rössig, C. (2022) · Cancers · doi:10.3390/cancers14092177 · Cited by 10
Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma
Wang, H., Li, J., & Xu, L. (2023) · Aging · doi:10.18632/aging.204764 · Cited by 9
Hypoxia-Induced miR-378a-3p Inhibits Osteosarcoma Invasion and Epithelial-to-Mesenchymal Transition via BYSL Regulation
Zhang, J., Tang, H., Jiang, X., Huang, N., & Wei, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.804952 · Cited by 9
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Sergi, C. M., Burnett, M., Jantuan, E., Hakoum, M., Beug, S. T., Leng, R. P., & Shen, F. (2025) · Biomedicines · doi:10.3390/biomedicines13030664 · Cited by 8
Pathobiology and Molecular Pathways Implicated in Osteosarcoma Lung Metastasis: A Scoping Review
Bashir, A., Ismail, A., Mavadia, A., Ghose, A., Ovsepian, S. V., & Boussios, S. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338251359716 · Cited by 10
Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma
Giordano, F., Lenna, S., Baudo, G., Rampado, R., Massaro, M., Rosa, E. D., Ewing, A., Kurenbekova, L., Agostini, M., Yustein, J. T., et al. (2022) · Cancer Nanotechnology · doi:10.1186/s12645-022-00146-7 · Cited by 8
Immune Environment and Osteosarcoma
Heymann, M., & Heymann, D. (2017) · InTech eBooks · doi:10.5772/67448 · Cited by 8
Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer
Yang, X., Pi, C., Zhang, Y., Chen, Z., Zhang, X., Zhu, D., Yang, L., Yin, J. C., Deng, J., Yang, M., et al. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23541 · Cited by 8
Craniofacial Osteosarcoma—Pilot Study on the Expression of Osteobiologic Characteristics and Hypothesis on Metastasis
Weber, M., Söder, S., Sander, J., Ries, J., Geppert, C. I., Kesting, M. R., & Wehrhan, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00745 · Cited by 8
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide
Byrgazov, K., Anderson, C. N., Salzer, B., Bozsaky, E., Larsson, R. L., Gullbo, J., Lehner, M., Lehmann, F., Slipicevic, A., Kager, L., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937891 · Cited by 8
Identification of a seven-gene prognostic signature using the gene expression profile of osteosarcoma
Liu, Z., Zhong, Y., Meng, S., Liao, Q., & Chen, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-6276 · Cited by 8
Single-Cell Spatial–Temporal Analysis ofZNF451in Mediating Drug Resistance and CD8+T Cell Dysfunction
Tang, N., Deng, W., Wu, Y., Deng, Z., Wu, X., Xiong, J., & Zhao, Q. (2024) · Research · doi:10.34133/research.0530 · Cited by 7
Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial
Beck, J. A., Garg, A., Church, S., Mazcko, C. N., & LeBlanc, A. K. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0687 · Cited by 7
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma
van Oost, S., Meijer, D. M., Erdem, Z. B., Ijsselsteijn, M. E., Roelands, J. P., Lam, S. W., Boejharat, M. S., van den Akker, B. E. W. M., van der Breggen, R., Bruijn, I. H. B., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04123-y · Cited by 8
Research trends and hotspots in the immune microenvironment related to osteosarcoma and tumor cell aging: a bibliometric and visualization study
Zhang, W., & Shao, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1289319 · Cited by 7
Spatiotemporal evolutionary process of osteosarcoma immune microenvironment remodeling and C1QBP‐driven drug resistance deciphered through single‐cell multi‐dimensional analysis
Wu, X., Tang, N., Zhao, Q., & Xiong, J. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10654 · Cited by 7
Potential predictive value of immune-related genes FUCA1 and NCKAP1L for osteosarcoma metastasis
Wang, X., Dou, J., Liu, M., Zhang, Y., Li, Y., & Tong, Z. (2024) · Gene · doi:10.1016/j.gene.2024.148645 · Cited by 7
Stratifying osteosarcoma patients using an epigenetic modification-related prognostic signature: implications for immunotherapy and chemotherapy selection
Li, Z., Xue, Y. Q., Huang, X., & Xiao, G. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2300 · Cited by 7
Development of a prognostic model for osteosarcoma based on macrophage polarization-related genes using machine learning: implications for personalized therapy
Zeng, J., Wang, D., Tong, Z., Li, Z., Wang, G., Du, Y., Li, J., Miao, J., & Chen, S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01530-w · Cited by 7
Tumorassoziierte Makrophagen
Niedobitek, G., Barros, M. H. M., Dreyer, J. H., Hauck, F., & Al-Sheikhyaqoob, D. (2015) · Der Pathologe · doi:10.1007/s00292-015-0054-7 · Cited by 7
Inhibition of osteosarcoma lung metastases by β-glucan and CD40 agonist is mediated by activation of macrophages and NK cells
Shrestha, P., Shrestha, R., & Kleinerman, E. S. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012510 · Cited by 6
Amino acid transporter SLC7A11 functions in ferroptosis regulation and immune microenvironment in osteosarcoma
Jia, X., Shi, Y., Su, J., Zhou, Y., Li, W., Li, Y., Di, B., An, F., & Yan, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115876 · Cited by 6
Bulk and single-cell sequencing identified a prognostic model based on the macrophage and lipid metabolism related signatures for osteosarcoma patients
Lin, Z., Wu, Z., & Luo, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26091 · Cited by 6
Identification of UNC5B as a novel aggressive biomarker for osteosarcoma based on basement membrane genes
Pan, R., Zhang, Y., Cheng, Y., Wu, Z., Liu, J., Chen, Z., Wang, J., Zhang, X., Wang, H., Feng, S., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148871 · Cited by 6
Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer
Lin, F., Yang, H., Huang, Z., Li, Y., Ding, Q., Ye, Y., & Qiu, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1464830 · Cited by 6
Immunotherapy
Cleton-Jansen, A., Buddingh, E. P., & Lankester, A. C. (2012) · OncoImmunology · doi:10.4161/onci.1.2.18345 · Cited by 6
Self-citation
Frequent expression of human leukocyte antigen class I and the status of intratumoral immune cells in alveolar soft part sarcoma
Ogose, A., Kawashima, H., Hotta, T., Ariizumi, T., Yamagishi, T., Oike, N., Sasaki, T., Hatano, K., Umezu, H., & Endo, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.5696 · Cited by 6
Functional Modulation of Human Macrophages by Secreted Phospholipases A2: Implications in Cancer
Galdiero, M. R., Mormile, I., Granata, F., Loffredo, S., Detoraki, A., Casa, F. D., Trocchia, M., Ventrici, A., de Paulis, A., & Rossi, F. W. (2022) · Biomedicines · doi:10.3390/biomedicines10112763 · Cited by 6
Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma
Chen, J., Guo, X., Zeng, G., Liu, J., & Zhao, B. (2020) · Computational and Mathematical Methods in Medicine · doi:10.1155/2020/8081973 · Cited by 6
Anoikis-related PLCB4 is linked to immunotherapy response in osteosarcoma
Liu, G., Yu, F., Li, J., & Chen, Z. (2025) · Discover Oncology · doi:10.1007/s12672-025-01970-0 · Cited by 5
Single-cell and multi-omics integrative modeling identifies mitochondrial gene HSPE1 as a therapeutic target in osteosarcoma
Pan, S., Hu, W., Xie, P., Zhang, Z., Ma, J., & Wang, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07633-6 · Cited by 5
New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival
Gong, L., Sun, X., & Jia, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-45566-6 · Cited by 5
Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment
Peng, C., You, C., Cao, S., Cheng, L., Ren, J., Cao, J., Wang, J., & Liu, T. (2025) · Analytical Cellular Pathology · doi:10.1155/ancp/6517238 · Cited by 5
Elevated expression of SKP2 correlates with poor prognosis in osteosarcoma: a bioinformatics analysis
Hoang, T.-M., Nguyen, M. T., Chen, W., Zhuang, C., Wang, Z., Wang, H., Li, J., & Lin, H. Q. (2021) · Biomedical Research and Therapy · doi:10.15419/bmrat.v8i12.714 · Cited by 5
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression
Watanabe, K., Tasaka, K., Ogata, H., Kato, S., Ueno, H., Umeda, K., Isobe, T., Kubota, Y., Sekiguchi, M., Kimura, S., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00773-9 · Cited by 5
Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF
Mustokoweni, S., Mahyudin, F., Setiawati, R., Nugrahenny, D., Hidayat, M., Kalim, H., Mintaroem, K., Fitri, L. E., & Hogendoorn, P. C. W. (2024) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-024-03801-z · Cited by 5
Self-citation
Bibliometric analysis and visualisation of research hotspots and frontiers on omics in osteosarcoma
Wang, X., Cao, X., Dai, Z., & Dai, Z. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05898-w · Cited by 5
Identification and Experimental Validation of Tumor Antigens and Hypoxia Subtypes of Osteosarcoma for Potential mRNA Vaccine Development
Ren, C., He, D., & Wang, Q. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673348041250407062346 · Cited by 5
Identification of key biomarkers involved in osteosarcoma using altered modules
Liu, Z. Z., Cui, S., Tang, B., Wang, Z. Z., & Luan, Z. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038277 · Cited by 5
Construction and Validation of an Autophagy-Related Prognostic Model for Osteosarcoma Patients
Hu, Q., Lei, T., Lei, P., & Hu, Y. (2021) · Journal of Oncology · doi:10.1155/2021/9943465 · Cited by 5
Molecular features and predictive models identify the most lethal subtype and a therapeutic target for osteosarcoma
Zheng, K., Hou, Y., Zhang, Y., Wang, F., Sun, A., & Dong, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1111570 · Cited by 5
Assessment of a novel nanoparticle hyperthermia therapy in a murine model of osteosarcoma
Tuohy, J. L., Fogle, J. E., Meichner, K., Borst, L. B., Petty, C. S., Griffith, E. H., Osborne, J. A., & Lascelles, B. D. X. (2018) · Veterinary Surgery · doi:10.1111/vsu.12959 · Cited by 5
Development of personalized classifier based on metastasis and the immune microenvironment to predict the prognosis of osteosarcoma patients
Zhang, Z., Yuan, J., Wang, Y., Zhang, Y., Guan, Z., Su, X., & Wang, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5856 · Cited by 4
Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction
Xie, L., Zeng, J., & He, M. (2023) · BMC Cancer · doi:10.1186/s12885-023-10660-5 · Cited by 4
Macrophage and osteosarcoma cell crosstalk is dependent on oxygen tension and 3D culture
Griffin, K. H., Sagheb, I. S., Coonan, T. P., Fierro, F. A., Randall, R. L., & Leach, J. K. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214154 · Cited by 4
C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter‐mediated doxorubicin resistance
Liu, C., Huang, J., Chang, H., Chen, C., Tsai, Y., Chen, W., Lin, J., Chang, H., Chen, C., Lin, M., et al. (2025) · The Journal of Pathology · doi:10.1002/path.6384 · Cited by 4
The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma
Lai, G., Zhao, X., Chen, Y., Xie, T., Su, Z., Lin, J., Chen, K., & Chen, K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114260 · Cited by 5
Comprehensive Analysis Reveals Prognostic and Therapeutic Immunity-Related Biomarkers for Pediatric Metastatic Osteosarcoma
Yuan, J., & Yu, S. (2024) · Medicina · doi:10.3390/medicina60010095 · Cited by 4
Exploration of metastasis-related signatures in osteosarcoma based on tumor microenvironment by integrated bioinformatic analysis
Liao, S., Gao, X., Zhou, K., Kang, Y., Ji, L., Zhong, X., & Lv, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41358 · Cited by 4
Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis
Li, R., Wang, G., Wu, Z., Lu, H., Li, G., Sun, Q., & Cai, M. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221992015 · Cited by 4
Comprehensive Analysis of a ceRNA Network Identifies lncR‐C3orf35 Associated with Poor Prognosis in Osteosarcoma
Shi, Y., Ren, J., Zhuang, Z., Zhang, W., Wang, Z., Liu, Y., Li, J., Liang, T., He, R., & Wang, K. (2020) · BioMed Research International · doi:10.1155/2020/3178037 · Cited by 4
Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives
Liang, G., Wang, W., Li, C., Zhong, B., Zhao, L., Zhang, Z., & Liu, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s579152 · Cited by 3
Breaking down the tumor immune infiltration within pediatric sarcomas
Weil, R., & Loeb, D. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1187289 · Cited by 4
Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
Zhou, Y., Li, G., Hu, L., Lai, F., Duan, P., & Cheng, M. L. (2022) · Journal of Immunology Research · doi:10.1155/2022/1377565 · Cited by 3
Construction of an integrated human osteosarcoma database, HOsDb, based on literature mining, microarray analysis, and database retrieval
Sun, Y., Wang, L., Li, C., Gu, R., Zang, W., Song, W., & Xia, P. (2020) · BMC Cancer · doi:10.1186/s12885-020-06719-2 · Cited by 3
Risk score model of autophagy-related genes in osteosarcoma
Jiang, M., Fang, D., He, X., Huang, J., Hu, Y., Xie, M., Jike, Y., Bo, Z., & Qin, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-166 · Cited by 3
Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma
Jackson, K. J., Sullivan, C. D., Zimel, M. N., Wustrack, R. L., & on behalf of the PARITY Investigators (2023) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.22.01077 · Cited by 3
The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma
Mo, C., Xie, L., Chen, C., Ma, J., Huang, Y., Wu, Y. X., Xu, Y., Peng, H., Chen, Z., & Mao, R. (2021) · Journal of Oncology · doi:10.1155/2021/7228584 · Cited by 3
Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
Feng, X., Zhao, Z., Zhao, Y., Song, Z., Ma, Y., & Wang, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.783915 · Cited by 3
Heterogenic membrane-coated nanoparticles for targeted immunotherapy against osteosarcoma via p53-mediated ferroptosis and mTOR inhibition
Lei, T., Jiang, Z., Nan, J., Fan, H., Yang, J., Wang, Y., Hua, L., Hu, Q., & Hu, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160854 · Cited by 2
Identification of potential genes associated with metastasis in osteosarcoma: an integrated bioinformatics analysis
Wiratnaya, I. G. E., Ismail, M. D., & Hasan, F. (2025) · MUSCULOSKELETAL SURGERY · doi:10.1007/s12306-025-00891-z · Cited by 2
Expression and Clinical Significance of Cytochrome 1B1 in Bone Sarcomas
Al-zu’bi, B., Alshammari, F. O. F. O., Alqaisi, R. S., Jaradat, J. H., Herzallah, M., Ja’Awin, M., Satari, A. O., Al-saraireh, Y. M., & Hareedy, M. S. (2025) · Pharmaceuticals · doi:10.3390/ph18101559 · Cited by 2
Basement membrane-associated gene P3H2 regulates osteosarcoma progression and epithelial-mesenchymal transition through AKT/mTOR signaling axis
Pan, R., Zhang, Y., Wang, H., Guan, J., Chen, Z., Xiao, L., Ru, N., Zhao, J., Cheng, Y., Feng, S., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102569 · Cited by 2
Single-cell dissection of PTM-related networks reveals an immunosuppressed osteosarcoma ecosystem
Chen, J., Zhang, W., Yan, H., Chen, J., Liu, H., Zhou, X., Zhang, H., & Cheng, D. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1718941 · Cited by 2
The synergistic role of ferroptosis in osteosarcoma immunotherapy
Tian, D., Yang, Z., Zhang, J., Yang, R., & Hao, H. (2025) · Medical Oncology · doi:10.1007/s12032-025-03196-0 · Cited by 2
Tetrahydropalmatine alleviates cancer induced bone pain by inhibiting TRPV1-SP-mediated macrophage recruitment and promoting M2 polarization
Zhang, Q., Chen, Z., Yu, Q., Wang, H., Jiang, Y., Zhou, L., Yu, G., Tang, Z., & Wang, C. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01359-3 · Cited by 2
Characterizing biomarkers in osteosarcoma metastasis based on an ego-network
Liu, Z., & Song, Y. (2017) · Biotechnology Letters · doi:10.1007/s10529-017-2305-6 · Cited by 2
Immune-related glycosylation genes based classification predicts prognosis and therapy options of osteosarcoma
Wang, W., Jiao, Y., Du, X., & Ye, Z. (2024) · Gene · doi:10.1016/j.gene.2024.148985 · Cited by 2
Integrated immunogenomic analyses of single-cell and bulk profiling construct a T cell-related signature for predicting prognosis and treatment response in osteosarcoma
Niu, C., Wang, W., Xu, Q., Tian, Z., Li, H., Ding, Q., Guo, L., & Zeng, P. (2024) · Discover Oncology · doi:10.1007/s12672-024-01461-8 · Cited by 2
Immunotherapy of Osteosarcoma
Sorteberg, A. L., Ek, L., Lilienthal, I., & Herold, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_236-1 · Cited by 2
A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma
Zhao, S., Wang, T., Huang, F., Zhao, Q., Gong, D., Liu, J., Yi, C., Liang, S., Bian, E., Tian, D., et al. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10446-1 · Cited by 2
A novel classification predicts prognosis and drug sensitivity in osteosarcoma based on alterations in gene sets
Ye, S., Wang, X., & Chen, R. (2024) · Aging · doi:10.18632/aging.205614 · Cited by 2
RNA modification‐related EIF4G2 is an immunotherapy determinant in osteosarcoma: A single‐cell sequencing analysis
Qin, H., Yang, S., Feng, Z., Wu, S. J., Cai, T., Xie, Z., & Hu, H. (2024) · Environmental Toxicology · doi:10.1002/tox.24261 · Cited by 2
Disulfidoptosis‐related molecular subtypes and prognostic model for optimizing drug therapy in metastatic osteosarcoma patients
Wang, X., Xie, C., & Lin, L. (2024) · The FASEB Journal · doi:10.1096/fj.202401510r · Cited by 2
Endothelial remodeling in osteosarcomas: insights from patient samples and in vitro studies
Legrand, M. A. (2025) · American Journal of Cancer Research · doi:10.62347/kyfo6159 · Cited by 2
Prognositic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma.
Wang, D., Deng, Q., Peng, Y., Tong, Z., Li, Z., Huang, L., Zeng, J., Li, J., Miao, J., & Chen, S. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.230519 · Cited by 1
Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases
Meijer, D. M., van Oost, S., Roelands, J. P., Ruano, D., Bruijn, I. H. B., van den Akker, B. E., Kruisselbrink, A. B., Wijers‐Koster, P. M., van der Ploeg, M., Ijsselsteijn, M. E., et al. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2024-000472 · Cited by 1
Self-citation
Construction and evaluation of a prognostic model based on the expression of the metabolism-related signatures in patients with osteosarcoma
Wu, T., & Wu, X. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08439-9 · Cited by 1
Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma
Husted, C. R., Adrianowycz, S., Peterson, C., DeWitt, S. B., Karlsson, E. K., Eward, W. C., Somarelli, J. A., Megquier, K., & Gardner, H. L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325181 · Cited by 1
Immunotherapy of Osteosarcoma
Sorteberg, A. L., Ek, L., Lilienthal, I., & Herold, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_236 · Cited by 1

Authors: Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., & Cleton-Jansen, A.-M.
Affiliations: Oslo University Hospital (NO)
Authors' Affiliations: 1Department of Pediatrics; 2Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; 3Institute of Pathology; 4Department of Medicine, Hematology and Oncology, University of Münster, Münster, Germany; 5Department of Tumor Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 6Laboratory of Experimental Oncology Research, Istituto Ortopedico Rizzoli, Bologna, Italy; and 7Department of Clinical Genetics, Lund University Hospital, Lund, Sweden
Corresponding author: Cleton-Jansen, Anne-Marie
ORCID: Buddingh, Emilie P.
Kuijjer, Marieke L.
Agelopoulos, Konstantin
Myklebost, Ola
Serra, Massimo
Mertens, Fredrik
Hogendoorn, Pancras C.W.
Lankester, Arjan C.
Cleton-Jansen, Anne-Marie
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2011-04-14
Volume: 17
Issue: 8
Pages: 2110-2119
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-10-2047
OpenAlex: W2106409672
Cited by: 508
References: 45
Citations by year: 2026: 27 · 2025: 45 · 2024: 48 · 2023: 63 · 2022: 47 · 2021: 54 · 2020: 50 · 2019: 24 · 2018: 20 · 2017: 36 · 2016: 24 · 2015: 17 · 2014: 15 · 2013: 13 · 2012: 18
FWCI: 7.52
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Leiden Repository (Leiden University) (submittedVersion)
Lund University Publications (Lund University) (submittedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: high-grade osteosarcoma, tumor-infiltrating macrophages, metastasis suppression, tumor-associated macrophages, tumor stroma, gene expression profiling, overall survival, muramyl tripeptide, adjuvant therapy, CD14, CD163, angiogenesis
MeSH terms: Bone Neoplasms, Humans, Immunohistochemistry, Macrophages, Neoplasm Metastasis, Prognosis, Osteosarcoma, Time Factors, Cohort Studies, Gene Expression Regulation, Neoplastic, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks